제이엘케이

322510KOSDAQ소프트웨어 개발 및 공급업

41.1 / 100

Reference Date: 2026-06-10

Financial Score7.0 / 40

News Sentiment21.1 / 25

Momentum3.0 / 20

Disclosure10.0 / 15

AI Analysis: the high debt ratio poses financial risk, ROE is below the industry average. Plunged 33.6% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

JLK is a medical AI solution provider specializing in AI-based analysis of medical imaging, with a focus on stroke diagnosis and prognosis prediction. The company holds 78 global certifications and offers products such as MEDIHUB STROKE and cancer analysis solutions, driving growth in both domestic and international markets.

Number of Employees

87people

Average Salary

88.9M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 13.624.0Point

PBR

2.70Industry Average 1.020.0Point

2.6x industry avg (risky)

ROE

-30.01Industry Average 1.100.0Point

Well below industry avg

Debt Ratio

21.64Industry Average 7.930.0Point

2.7x industry avg (risky)

Trend 2023~20253.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲45.6% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼40.9% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -41.9% (improving, 3yr)

Detailed News Sentiment

14 totalPositive 14Neutral 0Negative 0Average Sentiment Score 84.3

Positive
제이엘케이, 뇌졸중 AI '신의료기술평가 유예' 지정
제이엘케이의 뇌졸중 AI 솔루션이 신의료기술평가 유예 지정으로 인해 매출 및 수익성 향상 기대.
Positive
제이엘케이, 의료LLM 플랫폼 'JOOMED'…제약·바이오 사업 '확장...
제이엘케이의 새로운 의료 LLM 플랫폼 JOOMED 출시로 제약 및 바이오 분야 사업 확장 기대.
Positive
美 40개 신의료기기 메디케어 우선 적용...K의료기기 수혜 기업은?
미국 메디케어 우선 적용으로 제이엘케이의 의료기기 상용화 가능성이 높아져 긍정적 영향 예상.

Detailed Momentum

52-week position1.0Point

Near 52w low (5%, downtrend)

Current 4,335Won52-week high 9,00052-week low 4,045

1-month return0.0Point

1m -33.61% (strong drop)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0

Neutral기업설명회(IR)개최2026-05-29
Neutral분기보고서 (2026.03)2026-05-15